Oncolytics Reports About 15-Month Median Response Duration in Anal Cancer Trial
Oncolytics reported an about 15-month median response duration for a pelareorep combination in an anal cancer trial.
Oncolytics reported an about 15-month median response duration for a pelareorep combination in an anal cancer trial.